Atopic dermatitis.
Boguniewicz
Mark
M
Division of Pediatric Allergy-Immunology, National Jewish Medical and Research Center, 1400 Jackson Street, Denver, CO 80206, USA. boguniewiczm@njc.org
Schmid-Grendelmeier
Peter
P
Leung
Donald Y M
DY
D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D065095:Calcineurin Inhibitors; D003876:Dermatitis, Atopic / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D005512:Food Hypersensitivity / Q000175:diagnosis; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy; D000069444:Omalizumab; D012008:Recurrence; D012874:Skin Diseases, Infectious / Q000175:diagnosis; D012882:Skin Tests
D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D065095:Calcineurin Inhibitors; D006634:Histamine H1 Antagonists; D000069444:Omalizumab